Detoxifying capacity and kinetics of Prometheus® -: A new extracorporeal system for the treatment of liver failure

被引:57
作者
Evenepoel, P
Laleman, W
Wilmer, A
Claes, K
Maes, B
Kuypers, D
Bammens, B
Nevens, F
Vanrenterghem, Y
机构
[1] Univ Hosp Leuven, Dept Med, Div Nephrol, Louvain, Belgium
[2] Univ Hosp Leuven, Dept Med, Div Hepatol, Louvain, Belgium
[3] Univ Hosp Leuven, Dept Med, Div Med Intens Care, Louvain, Belgium
关键词
liver failure; dialysis; adsorption; albumin-bound toxins;
D O I
10.1159/000086885
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background/Aims: Extracorporeal liver support therapies have been used for several decades as a bridging therapy prior to liver transplantation or as an addendum to standard medical therapy. The Prometheus(R) system represents a cell-free, extracorporeal, liver assist method for the removal of both albumin-bound and water-soluble endogenous toxins. The aim of the present study was to evaluate the removal capacity and selectivity of the different inbuilt dialyzers and adsorption columns during a single 6-hour treatment. Methods: Nine patients with acute on chronic liver failure were included (6 females, age 49 +/- 4 years). Levels of endogenous toxins (urea nitrogen [UN, mg/dl], creatinine [Cr, mg/dl], total bilirubin [tB, mg/dl], and bile acids [BA, mu mol/l]) and albumin [Alb, g/l] were monitored in blood sampled at different sites (arterial line, venous line and between the absorbers and the high-flux dialyzer) and at various time points (time 0, 30, 60,120, 240, and 360 min). Results: A significant decrease of the serum level of all toxins was observed (UN 108.7 +/- 23.2 vs. 38.1 +/- 14.9, Cr 2.4 +/- 0.7 vs. 1.2 +/- 0.3, tB 31.1 +/- 4.1 vs. 17.0 +/- 1.6, BA 155.7 +/- 32.5 vs. 66.0 +/- 15.4; mean +/- SEM, time 0 vs. time 360, signed rank rest, all p < 0.005). The reduction rate of UN, Cr, tB and BA amounted to 68.1 +/- 5.1, 45.9 +/- 6.2, 41.2 +/- 5.1, and 58.2 +/- 5.0%, respectively. Blood clearances [CI, ml/min] of all, but especially of the protein-bound toxins declined overtime (CI UN 171.5 +/- 4.3 vs. 142.9 +/- 16.8; CI Cr 135.7 +/- 10.0 vs. 111.8 +/- 9.1; CI tB 29.3 +/- 5.1 vs. 13.7 +/- 3.7; CI BA 84.9 +/- 4.8 vs. 45.1 +/- 13.3; time 30 vs. time 360; linear mixed models, all p < 0.005). Serum albumin levels decreased by 2.9 +/- 0.9 g/l (signed rank test, p = 0.055). Not unexpectedly, tB was almost uniquely cleared by the adsorbers (UN 0.2 +/- 1.1, Cr 6.9 +/- 5.7, tB 92.3 +/- 4.21 BA 62.9 +/- 3.9% of total CO. Conclusion: Both albumin-bound and water-soluble toxins are adequately removed by the Prometheus(R) system. Our data suggest that the rate and efficacy of removal of albumin-bound toxins is related to both the strength of the albumin binding and the saturation of the adsorption columns. Limited losses of albumin occur during treatment with the Prometheus system. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:349 / 358
页数:10
相关论文
共 21 条
[1]
Ash SR, 2001, AM J KIDNEY DIS, V38, P219
[2]
Removal of the protein-bound solute p-cresol by convective transport: A randomized crossover study [J].
Bammens, B ;
Evenepoel, P ;
Verbeke, K ;
Vanrenterghem, Y .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2004, 44 (02) :278-285
[3]
Sieving coefficient inaccuracies during hemodiafiltration in patients with hyperbilirubinemia [J].
Chadha, V ;
Garg, U ;
Warady, BA ;
Alon, US .
PEDIATRIC NEPHROLOGY, 2000, 15 (1-2) :33-35
[4]
Detoxifying capacity and kinetics of the molecular adsorbent recycling system - Contribution of the different inbuilt filters [J].
Evenepoel, P ;
Maes, B ;
Wilmer, A ;
Nevens, F ;
Fevery, J ;
Kuypers, D ;
Bammens, B ;
Vanrenterghem, Y .
BLOOD PURIFICATION, 2003, 21 (03) :244-252
[5]
Fractionated plasma separation and adsorption system: A novel system for blood purification to remove albumin bound substances [J].
Falkenhagen, D ;
Strobl, W ;
Vogt, G ;
Schrefl, A ;
Linsberger, I ;
Gerner, FJ ;
Schoenhofen, M .
ARTIFICIAL ORGANS, 1999, 23 (01) :81-86
[6]
Acute liver failure [J].
Gill, RQ ;
Sterling, RK .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 2001, 33 (03) :191-198
[7]
Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy [J].
Kramer, L ;
Gendo, A ;
Madl, C ;
Ferrara, I ;
Funk, G ;
Schenk, P ;
Sunder-Plassmann, G ;
Hörl, WH .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (06) :1193-1200
[8]
Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins [J].
Kreymann, B ;
Seige, M ;
Schweigart, U ;
Kopp, KF ;
Classen, M .
JOURNAL OF HEPATOLOGY, 1999, 31 (06) :1080-1085
[9]
Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane [J].
Lesaffer, G ;
De Smet, R ;
Lameire, N ;
Dhondt, A ;
Duym, P ;
Vanholder, R .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 (01) :50-57
[10]
Mamianetti A, 2000, CLIN NEPHROL, V53, P194